<p>Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastasisfree survival (DMFS) and local-regional control (LRC) according to the microRNA signature in the testing data set (40 SCLC patients).</p
Kaplan-Meier estimates of progression-free and overall survival (PFS, OS) on iPET4 according to the ...
<p>Kaplan-Meier estimates of breast cancer-specific survival (A) and recurrence/metastasis-free surv...
<p>According to the prediction model, each patient was assigned to a low-risk or high-risk group. Si...
<p>Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastas...
<p>Kaplan-Meier analysis of cancer-specific survival in clear cell renal cell carcinoma (ccRCC) pati...
<p>They are all the testing cohort patients who are stratified by the 4-miRNA signature using microa...
<p>A) 92 patients in the training data set. B) 92 patients in the validation data set. C) Risk score...
<p>Kaplan-Meier estimates of breast cancer-specific survival (A) and recurrence/metastasis-free surv...
<p>The Kaplan-Meier overall survival curves of two outcome groups classified by MCPHR models using I...
(A) Disease-free survival (DFS) in early-stage patients and, (B) Progression-free survival (PFS) in ...
<p>(a) Overall survival in 145 patients with lung adenocarcinomas, (b) Overall survival in 99 Stage ...
Kaplan-Meier survival analysis for Overall Survival in early-stage and metastatic patients.</p
<p>(A) Overall survival and (B) progression-free survival according to baseline serum miR-21 levels ...
Kaplan-Meier analysis demonstrating the correlation between extracellular microvesicule (EV) miR-497...
<p>Kaplan-Meier analysis of the recurrence-free survival rates of patients with and without antitumo...
Kaplan-Meier estimates of progression-free and overall survival (PFS, OS) on iPET4 according to the ...
<p>Kaplan-Meier estimates of breast cancer-specific survival (A) and recurrence/metastasis-free surv...
<p>According to the prediction model, each patient was assigned to a low-risk or high-risk group. Si...
<p>Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastas...
<p>Kaplan-Meier analysis of cancer-specific survival in clear cell renal cell carcinoma (ccRCC) pati...
<p>They are all the testing cohort patients who are stratified by the 4-miRNA signature using microa...
<p>A) 92 patients in the training data set. B) 92 patients in the validation data set. C) Risk score...
<p>Kaplan-Meier estimates of breast cancer-specific survival (A) and recurrence/metastasis-free surv...
<p>The Kaplan-Meier overall survival curves of two outcome groups classified by MCPHR models using I...
(A) Disease-free survival (DFS) in early-stage patients and, (B) Progression-free survival (PFS) in ...
<p>(a) Overall survival in 145 patients with lung adenocarcinomas, (b) Overall survival in 99 Stage ...
Kaplan-Meier survival analysis for Overall Survival in early-stage and metastatic patients.</p
<p>(A) Overall survival and (B) progression-free survival according to baseline serum miR-21 levels ...
Kaplan-Meier analysis demonstrating the correlation between extracellular microvesicule (EV) miR-497...
<p>Kaplan-Meier analysis of the recurrence-free survival rates of patients with and without antitumo...
Kaplan-Meier estimates of progression-free and overall survival (PFS, OS) on iPET4 according to the ...
<p>Kaplan-Meier estimates of breast cancer-specific survival (A) and recurrence/metastasis-free surv...
<p>According to the prediction model, each patient was assigned to a low-risk or high-risk group. Si...